APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tacrolimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchTacrolimus Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tacrolimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Tacrolimus market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tacrolimus include GSK, Abbott, Takeda, Sichuan Med-Shine Pharmaceutical, Sandoz, Novartis, Mylan, Zhongmei Huadong Pharmaceutical and Hisun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tacrolimus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tacrolimus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tacrolimus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tacrolimus market size, projected growth trends, production technologies, key applications, and end-use industries.

Tacrolimus Segment by Company

GSK

Abbott

Takeda

Sichuan Med-Shine Pharmaceutical

Sandoz

Novartis

Mylan

Zhongmei Huadong Pharmaceutical

Hisun Pharmaceutical

Yamanouchi Pharmaceutical

Tecoland

Suzhou Pharmaceutical Technology

Squibb

Sinopharm Chuankang Pharmaceutical

Senju Pharmaceutical

ScinoPharm

RPG Life Science

Roche Pharma

Huapont Pharma

Guike Pharmaceutical

Fujisawa Pharmaceutical

Astellas

Accura Pharmaceuticals

Aarti Group

Tacrolimus Segment by Type

Tacrolimus Capsules

Tacrolimus Ointment

Tacrolimus Injection

Tacrolimus Segment by Application

Hospitals

Clinics

Other

Tacrolimus Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tacrolimus market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tacrolimus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tacrolimus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tacrolimus Industry Trends Table 2. Tacrolimus Industry Drivers Table 3. Tacrolimus Industry Opportunities and Challenges Table 4. Tacrolimus Industry Restraints Table 5. Global Tacrolimus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tacrolimus Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tacrolimus Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Tacrolimus Sales Market Share by Manufacturers Table 9. Global Tacrolimus Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Tacrolimus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tacrolimus Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tacrolimus Manufacturers, Product Type & Application Table 13. Global Tacrolimus Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tacrolimus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tacrolimus Capsules Table 17. Major Manufacturers of Tacrolimus Ointment Table 18. Major Manufacturers of Tacrolimus Injection Table 19. Global Tacrolimus Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Tacrolimus Sales by Type (2021-2026) & (K Tons) Table 21. Global Tacrolimus Sales by Type (2027-2032) & (K Tons) Table 22. Global Tacrolimus Sales Market Share by Type (2021-2026) Table 23. Global Tacrolimus Sales Market Share by Type (2027-2032) Table 24. Global Tacrolimus Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 25. Global Tacrolimus Revenue by Type (2021-2026) & (K Tons) Table 26. Global Tacrolimus Revenue by Type (2027-2032) & (K Tons) Table 27. Global Tacrolimus Revenue Market Share by Type (2021-2026) Table 28. Global Tacrolimus Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Other Table 32. Global Tacrolimus Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global Tacrolimus Sales by Application (2021-2026) & (K Tons) Table 34. Global Tacrolimus Sales by Application (2027-2032) & (K Tons) Table 35. Global Tacrolimus Sales Market Share by Application (2021-2026) Table 36. Global Tacrolimus Sales Market Share by Application (2027-2032) Table 37. Global Tacrolimus Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Tacrolimus Revenue by Application (2021-2026) & (K Tons) Table 39. Global Tacrolimus Revenue by Application (2027-2032) & (K Tons) Table 40. Global Tacrolimus Revenue Market Share by Application (2021-2026) Table 41. Global Tacrolimus Revenue Market Share by Application (2027-2032) Table 42. Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Tacrolimus Sales by Region (2021-2026) & (K Tons) Table 44. Global Tacrolimus Sales Market Share by Region (2021-2026) Table 45. Global Tacrolimus Sales Forecasted by Region (2027-2032) & (K Tons) Table 46. Global Tacrolimus Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 48. North America Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 49. North America Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 50. Europe Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 51. Europe Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 52. Europe Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 53. Asia Pacific Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 54. Asia Pacific Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 55. Asia Pacific Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 56. South America, Middle East and Africa Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 57. South America, Middle East and Africa Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 58. South America, Middle East and Africa Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 59. Global Tacrolimus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Tacrolimus Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Tacrolimus Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Tacrolimus Revenue Market Share by Region (2021-2026) Table 63. Global Tacrolimus Revenue Market Share by Region (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GSK Tacrolimus Product Portfolio Table 68. GSK Recent Development Table 69. Abbott Company Information Table 70. Abbott Business Overview Table 71. Abbott Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Abbott Tacrolimus Product Portfolio Table 73. Abbott Recent Development Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Takeda Tacrolimus Product Portfolio Table 78. Takeda Recent Development Table 79. Sichuan Med-Shine Pharmaceutical Company Information Table 80. Sichuan Med-Shine Pharmaceutical Business Overview Table 81. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio Table 83. Sichuan Med-Shine Pharmaceutical Recent Development Table 84. Sandoz Company Information Table 85. Sandoz Business Overview Table 86. Sandoz Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sandoz Tacrolimus Product Portfolio Table 88. Sandoz Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis Tacrolimus Product Portfolio Table 93. Novartis Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mylan Tacrolimus Product Portfolio Table 98. Mylan Recent Development Table 99. Zhongmei Huadong Pharmaceutical Company Information Table 100. Zhongmei Huadong Pharmaceutical Business Overview Table 101. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio Table 103. Zhongmei Huadong Pharmaceutical Recent Development Table 104. Hisun Pharmaceutical Company Information Table 105. Hisun Pharmaceutical Business Overview Table 106. Hisun Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Hisun Pharmaceutical Tacrolimus Product Portfolio Table 108. Hisun Pharmaceutical Recent Development Table 109. Yamanouchi Pharmaceutical Company Information Table 110. Yamanouchi Pharmaceutical Business Overview Table 111. Yamanouchi Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Yamanouchi Pharmaceutical Tacrolimus Product Portfolio Table 113. Yamanouchi Pharmaceutical Recent Development Table 114. Tecoland Company Information Table 115. Tecoland Business Overview Table 116. Tecoland Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Tecoland Tacrolimus Product Portfolio Table 118. Tecoland Recent Development Table 119. Suzhou Pharmaceutical Technology Company Information Table 120. Suzhou Pharmaceutical Technology Business Overview Table 121. Suzhou Pharmaceutical Technology Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio Table 123. Suzhou Pharmaceutical Technology Recent Development Table 124. Squibb Company Information Table 125. Squibb Business Overview Table 126. Squibb Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Squibb Tacrolimus Product Portfolio Table 128. Squibb Recent Development Table 129. Sinopharm Chuankang Pharmaceutical Company Information Table 130. Sinopharm Chuankang Pharmaceutical Business Overview Table 131. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio Table 133. Sinopharm Chuankang Pharmaceutical Recent Development Table 134. Senju Pharmaceutical Company Information Table 135. Senju Pharmaceutical Business Overview Table 136. Senju Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Senju Pharmaceutical Tacrolimus Product Portfolio Table 138. Senju Pharmaceutical Recent Development Table 139. ScinoPharm Company Information Table 140. ScinoPharm Business Overview Table 141. ScinoPharm Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. ScinoPharm Tacrolimus Product Portfolio Table 143. ScinoPharm Recent Development Table 144. RPG Life Science Company Information Table 145. RPG Life Science Business Overview Table 146. RPG Life Science Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. RPG Life Science Tacrolimus Product Portfolio Table 148. RPG Life Science Recent Development Table 149. Roche Pharma Company Information Table 150. Roche Pharma Business Overview Table 151. Roche Pharma Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Roche Pharma Tacrolimus Product Portfolio Table 153. Roche Pharma Recent Development Table 154. Huapont Pharma Company Information Table 155. Huapont Pharma Business Overview Table 156. Huapont Pharma Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Huapont Pharma Tacrolimus Product Portfolio Table 158. Huapont Pharma Recent Development Table 159. Guike Pharmaceutical Company Information Table 160. Guike Pharmaceutical Business Overview Table 161. Guike Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Guike Pharmaceutical Tacrolimus Product Portfolio Table 163. Guike Pharmaceutical Recent Development Table 164. Fujisawa Pharmaceutical Company Information Table 165. Fujisawa Pharmaceutical Business Overview Table 166. Fujisawa Pharmaceutical Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Fujisawa Pharmaceutical Tacrolimus Product Portfolio Table 168. Fujisawa Pharmaceutical Recent Development Table 169. Astellas Company Information Table 170. Astellas Business Overview Table 171. Astellas Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Astellas Tacrolimus Product Portfolio Table 173. Astellas Recent Development Table 174. Accura Pharmaceuticals Company Information Table 175. Accura Pharmaceuticals Business Overview Table 176. Accura Pharmaceuticals Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Accura Pharmaceuticals Tacrolimus Product Portfolio Table 178. Accura Pharmaceuticals Recent Development Table 179. Aarti Group Company Information Table 180. Aarti Group Business Overview Table 181. Aarti Group Tacrolimus Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. Aarti Group Tacrolimus Product Portfolio Table 183. Aarti Group Recent Development Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Tacrolimus Distributors List Table 187. Tacrolimus Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Tacrolimus Product Image Figure 2. Global Tacrolimus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tacrolimus Market Size (2021-2032) & (US$ Million) Figure 4. Global Tacrolimus Sales (2021-2032) & (K Tons) Figure 5. Global Tacrolimus Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Tacrolimus Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tacrolimus Capsules Image Figure 9. Tacrolimus Ointment Image Figure 10. Tacrolimus Injection Image Figure 11. Global Tacrolimus Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global Tacrolimus Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Tacrolimus Sales Market Share by Type (2021-2032) Figure 14. Global Tacrolimus Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global Tacrolimus Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Tacrolimus Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Other Image Figure 20. Global Tacrolimus Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global Tacrolimus Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Tacrolimus Sales Market Share by Application (2021-2032) Figure 23. Global Tacrolimus Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global Tacrolimus Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tacrolimus Revenue Market Share by Application (2021-2032) Figure 26. North America Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 27. North America Tacrolimus Sales Market Share by Country (2021-2032) Figure 28. U.S. Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Canada Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Mexico Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe Tacrolimus Sales Market Share by Country (2021-2032) Figure 33. Germany Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. France Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. U.K. Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Italy Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Netherlands Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific Tacrolimus Sales Market Share by Country (2021-2032) Figure 40. China Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Japan Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. South Korea Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Southeast Asia Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. India Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Australia Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa Tacrolimus Sales Market Share by Country (2021-2032) Figure 48. Brazil Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South Africa Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Saudi Arabia Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Turkey Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Argentina Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. UAE Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Egypt Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Chile Tacrolimus Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Global Tacrolimus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Tacrolimus Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Tacrolimus Revenue (2021-2032) & (US$ Million) Figure 59. North America Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Tacrolimus Revenue (2021-2032) & (US$ Million) Figure 61. Europe Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Tacrolimus Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Tacrolimus Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Tacrolimus Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Tacrolimus Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tacrolimus Capsules
  • Tacrolimus Ointment
  • Tacrolimus Injection
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • GSK
  • Abbott
  • Takeda
  • Sichuan Med-Shine Pharmaceutical
  • Sandoz
  • Novartis
  • Mylan
  • Zhongmei Huadong Pharmaceutical
  • Hisun Pharmaceutical
  • Yamanouchi Pharmaceutical
  • Tecoland
  • Suzhou Pharmaceutical Technology
  • Squibb
  • Sinopharm Chuankang Pharmaceutical
  • Senju Pharmaceutical
  • ScinoPharm
  • RPG Life Science
  • Roche Pharma
  • Huapont Pharma
  • Guike Pharmaceutical
  • Fujisawa Pharmaceutical
  • Astellas
  • Accura Pharmaceuticals
  • Aarti Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tacrolimus Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tacrolimus Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tacrolimus Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tacrolimus Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tacrolimus Market Dynamics
  1. 2.1 Tacrolimus Industry Trends
  2. 2.2 Tacrolimus Industry Drivers
  3. 2.3 Tacrolimus Industry Opportunities and Challenges
  4. 2.4 Tacrolimus Industry Restraints
3 Tacrolimus Market by Manufacturers
  1. 3.1 Global Tacrolimus Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tacrolimus Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tacrolimus Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tacrolimus Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tacrolimus Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tacrolimus Manufacturers, Product Type & Application
  7. 3.7 Global Tacrolimus Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tacrolimus Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tacrolimus Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tacrolimus Tier 1, Tier 2, and Tier 3
4 Tacrolimus Market by Type
  1. 4.1 Tacrolimus Type Introduction
  2. 4.1.1 Tacrolimus Capsules
  3. 4.1.2 Tacrolimus Ointment
  4. 4.1.3 Tacrolimus Injection
  5. 4.2 Global Tacrolimus Sales by Type
  6. 4.2.1 Global Tacrolimus Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tacrolimus Sales by Type (2021-2032)
  8. 4.2.3 Global Tacrolimus Sales Market Share by Type (2021-2032)
  9. 4.3 Global Tacrolimus Revenue by Type
  10. 4.3.1 Global Tacrolimus Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Tacrolimus Revenue by Type (2021-2032)
  12. 4.3.3 Global Tacrolimus Revenue Market Share by Type (2021-2032)
5 Tacrolimus Market by Application
  1. 5.1 Tacrolimus Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Tacrolimus Sales by Application
  6. 5.2.1 Global Tacrolimus Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tacrolimus Sales by Application (2021-2032)
  8. 5.2.3 Global Tacrolimus Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tacrolimus Revenue by Application
  10. 5.3.1 Global Tacrolimus Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tacrolimus Revenue by Application (2021-2032)
  12. 5.3.3 Global Tacrolimus Revenue Market Share by Application (2021-2032)
6 Global Tacrolimus Sales by Region
  1. 6.1 Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tacrolimus Sales by Region (2021-2032)
  3. 6.2.1 Global Tacrolimus Sales by Region (2021-2026)
  4. 6.2.2 Global Tacrolimus Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tacrolimus Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tacrolimus Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tacrolimus Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tacrolimus Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tacrolimus Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tacrolimus Revenue by Region
  1. 7.1 Global Tacrolimus Revenue by Region
  2. 7.1.1 Global Tacrolimus Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tacrolimus Revenue by Region (2021-2026)
  4. 7.1.3 Global Tacrolimus Revenue by Region (2027-2032)
  5. 7.1.4 Global Tacrolimus Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tacrolimus Revenue (2021-2032)
  8. 7.2.2 North America Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tacrolimus Revenue (2021-2032)
  11. 7.3.2 Europe Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tacrolimus Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tacrolimus Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tacrolimus Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Tacrolimus Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Tacrolimus Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Tacrolimus Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Sichuan Med-Shine Pharmaceutical
  20. 8.4.1 Sichuan Med-Shine Pharmaceutical Company Information
  21. 8.4.2 Sichuan Med-Shine Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
  24. 8.4.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Tacrolimus Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Tacrolimus Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Tacrolimus Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Zhongmei Huadong Pharmaceutical
  44. 8.8.1 Zhongmei Huadong Pharmaceutical Company Information
  45. 8.8.2 Zhongmei Huadong Pharmaceutical Business Overview
  46. 8.8.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
  48. 8.8.5 Zhongmei Huadong Pharmaceutical Recent Developments
  49. 8.9 Hisun Pharmaceutical
  50. 8.9.1 Hisun Pharmaceutical Company Information
  51. 8.9.2 Hisun Pharmaceutical Business Overview
  52. 8.9.3 Hisun Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
  54. 8.9.5 Hisun Pharmaceutical Recent Developments
  55. 8.10 Yamanouchi Pharmaceutical
  56. 8.10.1 Yamanouchi Pharmaceutical Company Information
  57. 8.10.2 Yamanouchi Pharmaceutical Business Overview
  58. 8.10.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
  60. 8.10.5 Yamanouchi Pharmaceutical Recent Developments
  61. 8.11 Tecoland
  62. 8.11.1 Tecoland Company Information
  63. 8.11.2 Tecoland Business Overview
  64. 8.11.3 Tecoland Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tecoland Tacrolimus Product Portfolio
  66. 8.11.5 Tecoland Recent Developments
  67. 8.12 Suzhou Pharmaceutical Technology
  68. 8.12.1 Suzhou Pharmaceutical Technology Company Information
  69. 8.12.2 Suzhou Pharmaceutical Technology Business Overview
  70. 8.12.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
  72. 8.12.5 Suzhou Pharmaceutical Technology Recent Developments
  73. 8.13 Squibb
  74. 8.13.1 Squibb Company Information
  75. 8.13.2 Squibb Business Overview
  76. 8.13.3 Squibb Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Squibb Tacrolimus Product Portfolio
  78. 8.13.5 Squibb Recent Developments
  79. 8.14 Sinopharm Chuankang Pharmaceutical
  80. 8.14.1 Sinopharm Chuankang Pharmaceutical Company Information
  81. 8.14.2 Sinopharm Chuankang Pharmaceutical Business Overview
  82. 8.14.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
  84. 8.14.5 Sinopharm Chuankang Pharmaceutical Recent Developments
  85. 8.15 Senju Pharmaceutical
  86. 8.15.1 Senju Pharmaceutical Company Information
  87. 8.15.2 Senju Pharmaceutical Business Overview
  88. 8.15.3 Senju Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Senju Pharmaceutical Tacrolimus Product Portfolio
  90. 8.15.5 Senju Pharmaceutical Recent Developments
  91. 8.16 ScinoPharm
  92. 8.16.1 ScinoPharm Company Information
  93. 8.16.2 ScinoPharm Business Overview
  94. 8.16.3 ScinoPharm Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ScinoPharm Tacrolimus Product Portfolio
  96. 8.16.5 ScinoPharm Recent Developments
  97. 8.17 RPG Life Science
  98. 8.17.1 RPG Life Science Company Information
  99. 8.17.2 RPG Life Science Business Overview
  100. 8.17.3 RPG Life Science Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 RPG Life Science Tacrolimus Product Portfolio
  102. 8.17.5 RPG Life Science Recent Developments
  103. 8.18 Roche Pharma
  104. 8.18.1 Roche Pharma Company Information
  105. 8.18.2 Roche Pharma Business Overview
  106. 8.18.3 Roche Pharma Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Roche Pharma Tacrolimus Product Portfolio
  108. 8.18.5 Roche Pharma Recent Developments
  109. 8.19 Huapont Pharma
  110. 8.19.1 Huapont Pharma Company Information
  111. 8.19.2 Huapont Pharma Business Overview
  112. 8.19.3 Huapont Pharma Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Huapont Pharma Tacrolimus Product Portfolio
  114. 8.19.5 Huapont Pharma Recent Developments
  115. 8.20 Guike Pharmaceutical
  116. 8.20.1 Guike Pharmaceutical Company Information
  117. 8.20.2 Guike Pharmaceutical Business Overview
  118. 8.20.3 Guike Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Guike Pharmaceutical Tacrolimus Product Portfolio
  120. 8.20.5 Guike Pharmaceutical Recent Developments
  121. 8.21 Fujisawa Pharmaceutical
  122. 8.21.1 Fujisawa Pharmaceutical Company Information
  123. 8.21.2 Fujisawa Pharmaceutical Business Overview
  124. 8.21.3 Fujisawa Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
  126. 8.21.5 Fujisawa Pharmaceutical Recent Developments
  127. 8.22 Astellas
  128. 8.22.1 Astellas Company Information
  129. 8.22.2 Astellas Business Overview
  130. 8.22.3 Astellas Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Astellas Tacrolimus Product Portfolio
  132. 8.22.5 Astellas Recent Developments
  133. 8.23 Accura Pharmaceuticals
  134. 8.23.1 Accura Pharmaceuticals Company Information
  135. 8.23.2 Accura Pharmaceuticals Business Overview
  136. 8.23.3 Accura Pharmaceuticals Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
  138. 8.23.5 Accura Pharmaceuticals Recent Developments
  139. 8.24 Aarti Group
  140. 8.24.1 Aarti Group Company Information
  141. 8.24.2 Aarti Group Business Overview
  142. 8.24.3 Aarti Group Tacrolimus Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Aarti Group Tacrolimus Product Portfolio
  144. 8.24.5 Aarti Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tacrolimus Value Chain Analysis
  2. 9.1.1 Tacrolimus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tacrolimus Production Mode & Process
  6. 9.2 Tacrolimus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tacrolimus Distributors
  9. 9.2.3 Tacrolimus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst